Commercial Services and Supplies
Company Overview of Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America (PhRMA) represents the research-based pharmaceutical and biotechnology companies. The company advocates for public policies that encourage discovery of new medicines for patients by pharmaceutical and biotechnology research companies. Its members consist of 3M Pharmaceuticals, Berlex Laboratories, Inc., GE Healthcare, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Millennium Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Wyeth, and Pfizer Inc. PhRMA was founded in 1958 and is based in Washington, DC.
950 F Street, NW
Washington, DC 20004
Founded in 1958
Key Executives for Pharmaceutical Research and Manufacturers of America
Chief Executive Officer and President
President of International Section
Senior Vice President of External Affairs
Senior Vice President of Communications
Compensation as of Fiscal Year 2014.
Pharmaceutical Research and Manufacturers of America Key Developments
Pharmaceutical Research and Manufacturers of America Announces Executive and Board Changes
Apr 17 15
Kenneth C. Frazier, chairman and chief executive officer (CEO) of Merck & Co. Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA). At Board meeting, PhRMA's president and CEO John J. Castellani announced that he will be retiring effective January 1, 2016. Frazier formerly held the position of chairman-elect and succeeds Ian C. Read, chairman and CEO of Pfizer Inc. Also elected were George A. Scangos, Ph.D., CEO of Biogen, as chairman-elect of the PhRMA Board of Directors and Joaquin Duato, worldwide chairman, pharmaceuticals, Johnson & Johnson, as Board treasurer. Before becoming chairman and CEO of Merck in 2011, Frazier served as president of Merck. Dr. Scangos was appointed CEO of Biogen in June 2010. Castellani will step down as president and CEO of PhRMA after successfully leading the association since September 2010. Frazier announced that the search for Castellani's successor will begin immediately and will be led by the PhRMA Board's Nominations and Compensation Committee. Korn Ferry has been retained to conduct the search.
Pharmaceutical Research and Manufacturers of America Appoints Christina ("Tina") Stow as Vice President of Communications, Effective October 27, 2014
Oct 20 14
The Pharmaceutical Research and Manufacturers of America announced that Christina ("Tina") Stow will join the organization as Vice President of Communications, effective October 27, 2014. Stow will play a key leadership role within the communications department. She will oversee a team responsible for the day-to-day activities associated with media relations, including message development, proactive media outreach, rapid response, message research and relationship-building with key reporters and influencers. Stow will report to Robert Zirkelbach, Senior Vice President of Communications. Stow comes to PhRMA from APCO Worldwide, where she was Co-Practice Lead of the firm's Corporate Communications and Issues Management service group where she most recently helped design and execute communications strategies for organizations navigating the ongoing implementation of the Affordable Care Act.
Ieva M. Augstums to Join The Pharmaceutical Research and Manufacturers of America as Deputy Vice President of Communications and Public Affairs, Effective October 1, 2014
Sep 29 14
The Pharmaceutical Research and Manufacturers of America announced that Ieva M. Augstums will join the organization as Deputy Vice President of Communications and Public Affairs, effective October 1, 2014. Augstums will be responsible for developing and executing PR campaigns, overseeing paid media activities, leading the planning and promotion of key annual events, and supervising message research and public polling activities. She will be an important part of the leadership team in the communications department, helping to craft and drive the overall communications strategy for the association. She will report to Robert Zirkelbach, Senior Vice President of Communications. Augstums comes to PhRMA from Purple Strategies, LLC, where she oversaw strategic communications campaigns and brand consulting.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|